Is a complete CTOR research report available?

No complete published report is available for Citius Oncology, Inc. (CTOR) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Citius Oncology, Inc. (CTOR)

NASDAQ: CTOR · USD

$0.55

-0.04 (-7.4%)· Recorded snapshot

Market cap	58.2M
Revenue (ttm)	7.1M
Net income (ttm)	-46.1M
EPS (ttm)	-$0.49
Shares out	105.8M
Volume	188,285.328
Beta	3.57

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 7.1M
Net income (ttm): -46.1M
EPS (ttm): -$0.49
Market cap: 58.2M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	نگه‌داری

Metric	Value
Amount currency	USD
CIK code	0001851484
Company name	Citius Oncology, Inc.
Country	United States
Country code	US
CUSIP number	17331Y109
Earnings date	2026-12-22
Earnings time	amc
Enterprise value	$51.8M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	September
Founded	2021
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	Yes
Is SPAC	No
ISIN number	US17331Y1091
Last 10-K release date	2025-12-23
Last earnings date	2026-08-14
Last refreshed	2026-11-04
Last stock split type	Never
Market cap	$58.2M
Market cap category	Micro-Cap
Next earnings date	2026-12-22
Options	No
Price	$0.55
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-11-03
Symbol	CTOR
U.S. state	New Jersey
Website	https://citiusonc.com/overview/default.aspx

Metric

Value

Amount currency

USD

CIK code

0001851484

Company name

Citius Oncology, Inc.

Country

United States

Country code

CUSIP number

17331Y109

Earnings date

2026-12-22

Earnings time

amc

Enterprise value

$51.8M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

September

Founded

2021

Industry

Drug Manufacturers - Specialty & Generic

Is primary listing

Yes

Is SPAC

ISIN number

US17331Y1091

Last 10-K release date

2025-12-23

Last earnings date

2026-08-14

Last refreshed

2026-11-04

Last stock split type

Never

Market cap

$58.2M

Market cap category

Micro-Cap

Next earnings date

2026-12-22

Options

Price

$0.55

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-11-03

Symbol

CTOR

U.S. state

New Jersey

Website

https://citiusonc.com/overview/default.aspx

Metric	Value
Earnings yield	-89.66%
EV/Sales	7.29x
FCF / EV yield	-37.42%
FCF yield	-33.33%
Forward EV/Sales	0.75x
Forward P/S	0.84x
Industry forward P/E	14.04x
Industry P/E	107.82x
P/B ratio	1.44x
P/S ratio	8.19x
Price / tangible book value	1.44x
Sector forward P/E	23.32x
Sector P/E	49.47x

Metric

Value

Earnings yield

-89.66%

EV/Sales

7.29x

FCF / EV yield

-37.42%

FCF yield

-33.33%

Forward EV/Sales

0.75x

Forward P/S

0.84x

Industry forward P/E

14.04x

Industry P/E

107.82x

P/B ratio

1.44x

P/S ratio

8.19x

Price / tangible book value

1.44x

Sector forward P/E

23.32x

Sector P/E

49.47x

Metric	Value
Gross margin	74.82%
Operating margin	-668.15%
Pretax margin	-645.64%
ROA	-29.12%
ROCE	-89.06%
ROE	-126.58%
ROIC	-68.37%
SBC / revenue	187.77%
Tax / revenue	2.67%

Metric

Value

Gross margin

74.82%

Operating margin

-668.15%

Pretax margin

-645.64%

ROA

-29.12%

ROCE

-89.06%

ROE

-126.58%

ROIC

-68.37%

SBC / revenue

187.77%

Tax / revenue

2.67%

Metric	Value
EPS growth years	0
Net income growth years	0
Revenue growth (QoQ)	-10.41%
Revenue growth years	0

Metric

Value

EPS growth years

Net income growth years

Revenue growth (QoQ)

-10.41%

Revenue growth years

Metric	Value
EBIT	$-47.5M
EPS	$-0.49
FCF per share	$-0.18
Financing cash flow	$48.7M
Free cash flow	$-19.4M
Free cash flow minus SBC	$-32.7M
Gross profit	$5.3M
Income taxes	$189,923
Investing cash flow	$-12.8M
Net borrowing	$9.6M
Net cash flow	$16.6M
Net income	$-46.1M
Operating cash flow minus SBC	$-32.7M
Operating income	$-47.5M
Revenue	$7.1M
Stock-based compensation	$13.3M

Metric

Value

EBIT

$-47.5M

EPS

$-0.49

FCF per share

$-0.18

Financing cash flow

$48.7M

Free cash flow

$-19.4M

Free cash flow minus SBC

$-32.7M

Gross profit

$5.3M

Income taxes

$189,923

Investing cash flow

$-12.8M

Net borrowing

$9.6M

Net cash flow

$16.6M

Net income

$-46.1M

Operating cash flow minus SBC

$-32.7M

Operating income

$-47.5M

Revenue

$7.1M

Stock-based compensation

$13.3M

Metric	Value
Altman Z-Score	-1.88
Book value per share	$0.38
Debt / equity	0.25
Interest coverage	-129.05
Long-term assets	$69.4M
Long-term liabilities	$12.9M
Net cash (debt)	$6.4M
Net cash / market cap	10.92%
Net debt / equity	-0.16
Piotroski F-Score	2
Shareholders' equity	$40.4M
Tangible book value	$40.4M
Tangible book value per share	$0.38
Total assets	$112.1M
Total cash	$16.6M
Total debt	$10.2M
Total liabilities	$71.7M
WACC	20.76%

Metric

Value

Altman Z-Score

-1.88

Book value per share

$0.38

Debt / equity

0.25

Interest coverage

-129.05

Long-term assets

$69.4M

Long-term liabilities

$12.9M

Net cash (debt)

$6.4M

Net cash / market cap

10.92%

Net debt / equity

-0.16

Piotroski F-Score

Shareholders' equity

$40.4M

Tangible book value

$40.4M

Tangible book value per share

$0.38

Total assets

$112.1M

Total cash

$16.6M

Total debt

$10.2M

Total liabilities

$71.7M

WACC

20.76%

Metric	Value
Asset turnover	0.07
Current assets	$42.7M
Current liabilities	$58.8M
Current ratio	0.73
Inventory turnover	0.09
Net working capital	$-32.6M
Quick ratio	0.29
Working capital	$-16.1M
Working capital turnover	-0.28

Metric

Value

Asset turnover

0.07

Current assets

$42.7M

Current liabilities

$58.8M

Current ratio

0.73

Inventory turnover

0.09

Net working capital

$-32.6M

Quick ratio

0.29

Working capital

$-16.1M

Working capital turnover

-0.28

Metric	Value
Buyback yield / dilution	-31.4%
Dividend yield	0%
Shareholder yield	-31.4%

Metric

Value

Buyback yield / dilution

-31.4%

Dividend yield

Shareholder yield

-31.4%

Metric	Value
150-day SMA	$0.78
1D price change	-7.42%
1M price change	-42.11%
1M total return	-42.11%
1W price change	-9.98%
1W total return	-9.98%
1Y price change	-68.57%
1Y return CAGR	-68.6%
1Y total return	-68.57%
20-day SMA	$0.69
200-day SMA	$0.83
3M price change	-7.14%
3M total return	-7.14%
3Y price change	-94.95%
3Y return CAGR	-63.04%
3Y total return	-94.95%
50-day SMA	$0.83
50-day SMA vs 200-day SMA	50under200
52-week high	$1.83
52-week high date	2025-12-01
52-week low	$0.49
52-week low date	2026-03-30
6M price change	-41.79%
6M total return	-41.79%
After-hours change	1%
After-hours close	$0.55
After-hours price	$0.56
All-time high	$49.00
All-time high date	2024-08-06
All-time low	$0.49
All-time low date	2026-03-30
Average true range (ATR)	$0.09
Average volume	144.4K
Beta (1Y)	4.62
Beta (2Y)	2.87
Beta (5Y)	3.57
Change from 52-week high	-69.95%
Change from 52-week low	11.97%
Change from all-time high	-98.88%
Change from all-time low	11.97%
Change from open	-9.57%
Day's gap	2.37%
Dollar volume	$103,557
High price	$0.62
Low price	$0.55
Monthly RSI	32.59
Open price	$0.61
Position in 52-week range	4.28%
Premarket change	2.82%
Premarket close	$0.55
Premarket price	$0.57
Premarket volume	200
Previous close	$0.59
Price vs 150-day SMA	-29.45%
Price vs 20-day SMA	-20.29%
Price vs 200-day SMA	-33.74%
Price vs 50-day SMA	-33.7%
Relative volume	1.3
RSI	32.35
Sharpe ratio	-0.8
Sharpe ratio (3Y)	0.21
Sortino ratio	-1.1
Sortino ratio (3Y)	0.45
Volume	188.3K
Weekly RSI	39.15
YTD price change	-45%
YTD total return	-45%

Metric

Value

150-day SMA

$0.78

1D price change

-7.42%

1M price change

-42.11%

1M total return

-42.11%

1W price change

-9.98%

1W total return

-9.98%

1Y price change

-68.57%

1Y return CAGR

-68.6%

1Y total return

-68.57%

20-day SMA

$0.69

200-day SMA

$0.83

3M price change

-7.14%

3M total return

-7.14%

3Y price change

-94.95%

3Y return CAGR

-63.04%

3Y total return

-94.95%

50-day SMA

$0.83

50-day SMA vs 200-day SMA

50under200

52-week high

$1.83

52-week high date

2025-12-01

52-week low

$0.49

52-week low date

2026-03-30

6M price change

-41.79%

6M total return

-41.79%

After-hours change

After-hours close

$0.55

After-hours price

$0.56

All-time high

$49.00

All-time high date

2024-08-06

All-time low

$0.49

All-time low date

2026-03-30

Average true range (ATR)

$0.09

Average volume

144.4K

Beta (1Y)

4.62

Beta (2Y)

2.87

Beta (5Y)

3.57

Change from 52-week high

-69.95%

Change from 52-week low

11.97%

Change from all-time high

-98.88%

Change from all-time low

11.97%

Change from open

-9.57%

Day's gap

2.37%

Dollar volume

$103,557

High price

$0.62

Low price

$0.55

Monthly RSI

32.59

Open price

$0.61

Position in 52-week range

4.28%

Premarket change

2.82%

Premarket close

$0.55

Premarket price

$0.57

Premarket volume

200

Previous close

$0.59

Price vs 150-day SMA

-29.45%

Price vs 20-day SMA

-20.29%

Price vs 200-day SMA

-33.74%

Price vs 50-day SMA

-33.7%

Relative volume

1.3

RSI

32.35

Sharpe ratio

-0.8

Sharpe ratio (3Y)

0.21

Sortino ratio

-1.1

Sortino ratio (3Y)

0.45

Volume

188.3K

Weekly RSI

39.15

YTD price change

-45%

YTD total return

-45%

Metric	Value
Float	31M
Float percentage	29.3%
Shares change (QoQ)	7.86%
Shares change (YoY)	31.4%
Shares held by insiders	0.02%
Shares held by institutions	5.2%
Shares outstanding	105.8M
Short % of float	0.73%
Short % of shares	0.22%
Short ratio	2.1 days

Metric

Value

Float

31M

Float percentage

29.3%

Shares change (QoQ)

7.86%

Shares change (YoY)

31.4%

Shares held by insiders

0.02%

Shares held by institutions

5.2%

Shares outstanding

105.8M

Short % of float

0.73%

Short % of shares

0.22%

Short ratio

2.1 days

Citius Oncology, Inc. (CTOR)

Price

Financial snapshot

Fair-value bridge

Latest news · CTOR

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CTOR indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on CTOR

Frequently asked questions